Albert Berger is the Chief Executive Officer of Confirm Biosciences, which was acquired by CRL in 2021. Before joining Confirm Biosciences, Albert was the CEO of Redwood Toxicology Laboratory, the largest single-site drug testing laboratory in the world, featuring a broad drug and alcohol testing portfolio that includes visual-read screening devices and laboratory testing services. In 2008, he led the acquisition of Redwood Toxicology Laboratory, Inc. by Alere (NYSE: ALR) on behalf of shareholders and private equity ownership group American Capital Strategies (NASDAQ:ACAS). In 2006, he negotiated the acquisition of Redwood Toxicology Laboratory Inc. to American Capital Strategies (ACAS). Previous experience included management roles at Tyco Electronics and United Parcel Service. Albert earned his MBA from Saint Mary’s College and a BS in Organizational Communication from the Hugh Downs School of Communication at Arizona State University.
Current role